<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000285947">
  <TermName>rapamycin</TermName>
  <TermPronunciation>(RA-puh-MY-sin)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug used to keep the body from rejecting organ and bone marrow transplants. Rapamycin blocks certain white blood cells that can reject foreign tissues and organs.  It also blocks a protein that is involved in cell division. It is a type of antibiotic, a type of immunosuppressant, and a type of serine/threonine kinase inhibitor. Rapamycin is now called sirolimus.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000710107" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;rapamycin&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000710108" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;rapamicina&quot;" language="es" id="_4"/>
  <SpanishTermName>rapamicina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que se usa para impedir que el cuerpo rechace los trasplantes de órganos o médula ósea. La rapamicina  impide que ciertos glóbulos blancos rechacen tejidos y órganos ajenos. También bloquea una proteína que participa en la división celular. Es un tipo de antibiótico, de inmunodepresor y de inhibidor de la cinasa serina/treonina. La rapamicina ahora se llama sirólimus.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2003-02-21</DateFirstPublished>
  <DateLastModified>2009-09-30</DateLastModified>
</GlossaryTerm>
